Skip to content
drillr.ai
Sign up

UNCY

Unicycive Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.75
+4.46%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-29.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 29, 2026Manning Meredith · directorA-Award27,000$3.76
Oct 29, 2026Manning Meredith · directorA-Award3,350$0.00
Jul 28, 2026Kenkare-Mitra Sara · directorA-Award47,941$0.00
Jul 28, 2026Laumas Sandeep · directorA-Award47,941$0.00
May 21, 2026Kenkare-Mitra Sara · directorA-Award84,200$0.00
May 21, 2026Gupta Shalabh K. · director, officer: CEOA-Award762,200$0.00
May 21, 2026Kenkare-Mitra Sara · directorA-Award42,100$0.00
May 20, 2026Gupta Pramod · officer: EVP, Pharmaceuticals and BDA-Award169,500$0.00
May 20, 2026Jermasek Douglas · officer: EVP, Corporate StrategyA-Award169,500$0.00
May 20, 2026Townsend John · officer: CFOA-Award169,500$0.00
May 18, 2026Laumas Sandeep · directorA-Award42,100$0.00
May 18, 2026Laumas Sandeep · directorA-Award84,200$0.00
Jul 30, 2025Aggarwal Gaurav · directorA-Award21,200$4.71
Jul 30, 2025Jermasek Douglas · officer: EVP of Corporate StrategyA-Award10,000$4.71
Jul 30, 2025Gupta Pramod · officer: EVP, Pharmaceuticals and BDA-Award90,000$4.71
Jul 30, 2025Townsend John · officer: Chief Financial OfficerA-Award10,000$4.71
Jul 30, 2025Gupta Shalabh K. · director, officer: CEOA-Award325,000$4.71
Jul 30, 2025Kenkare-Mitra Sara · directorA-Award21,200$4.71
Jul 30, 2025Laumas Sandeep · directorA-Award21,200$4.71
Aug 14, 2024Townsend John · officer: Chief Financial OfficerA-Award40,256$0.34
Aug 14, 2024Gupta Pramod · officer: EVP, Pharmaceuticals and BDA-Award81,750$0.34
Aug 14, 2024Jermasek Douglas · officer: EVP of Corporate StrategyA-Award81,750$0.34
Aug 14, 2024Gupta Shalabh K. · director, officer: CEOA-Award232,868$0.34
Apr 17, 2024Townsend John · officer: Chief Financial OfficerA-Award228,119$1.14
Apr 17, 2024Jermasek Douglas · officer: EVP of Corporate StrategyA-Award463,250$1.14
Apr 17, 2024Gupta Pramod · officer: EVP, Pharmaceuticals and BDA-Award463,250$1.14
Apr 17, 2024Gupta Shalabh K. · director, 10 percent owner, officer: CEOA-Award1,319,583$1.14
Sep 7, 2023Laumas Sandeep · directorA-Award189,236$0.76
Sep 7, 2023Kenkare-Mitra Sara · directorA-Award180,000$0.76
Sep 7, 2023Ryan John L · directorA-Award112,147$0.76
Institutional positioning

13F filings over the trailing two quarters

New 58Increased 38Reduced 18Sold out 12
FilerActionSharesFiled
VIVO CAPITAL, LLCUnchanged1,789,916May 20, 2026
BlackRock, Inc.Increased1,413,381Aug 7, 2026
Nantahala Capital Management, LLCIncreased1,401,447Aug 19, 2026
MILLENNIUM MANAGEMENT LLCIncreased1,399,348May 15, 2026
DIADEMA PARTNERS LPIncreased1,096,276Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased1,071,481Aug 13, 2026
Octagon Capital Advisors LPUnchanged1,000,000Aug 14, 2026
OCTAGON CAPITAL ADVISORS LPUnchanged1,000,000May 15, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCUnchanged939,202May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position811,430May 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased809,639Aug 14, 2026
GREAT POINT PARTNERS LLCUnchanged796,558May 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased598,319May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased564,019Aug 12, 2026
Vivo Capital, LLCReduced550,000Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 29, 2026